Literature DB >> 2217144

Mutational analysis of structure--activity relationships in human tumor necrosis factor-alpha.

J Yamagishi1, H Kawashima, N Matsuo, M Ohue, M Yamayoshi, T Fukui, H Kotani, R Furuta, K Nakano, M Yamada.   

Abstract

To determine the region of human tumor necrosis factor-alpha (TNF-alpha), essential for cytotoxic activity against mouse L-M cells, single amino-acid-substituted TNF-alpha mutant proteins (muteins) were produced in Escherichia coli by protein engineering techniques. An expression plasmid for TNF-alpha was mutagenized by passage through an E. coli mutD5 mutator strain and by oligonucleotide-directed mutagenesis. Approximately 100 single amino-acid-substituted TNF-alpha muteins were produced and assayed for cytotoxic activity. The cytotoxic activities of purified TNF-alpha muteins, e.g. TNF-31T, -32Y, -82D, -85H, -115L, -141Y, -144K and -146E, were less than 1% of that of parent TNF-alpha. These results indicate that the integrity of at least four distinct regions of the TNF-alpha molecule is required for full biological activity. These regions are designated as follows: region I, from position 30 to 32; region II, from position 82 to 89; region III, from position 115 to 117; region IV, from position 141 to 146. In addition, TNF-141Y could not completely compete with parent TNF-alpha for binding to the receptor. This demonstrates that region IV, and at least aspartic acid at position 141, must be involved in the TNF receptor binding site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217144     DOI: 10.1093/protein/3.8.713

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  18 in total

1.  A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.

Authors:  Kazuhiro Aoki; Hiroaki Saito; Cecile Itzstein; Masaji Ishiguro; Tatsuya Shibata; Roland Blanque; Anower Hussain Mian; Mariko Takahashi; Yoshifumi Suzuki; Masako Yoshimatsu; Akira Yamaguchi; Pierre Deprez; Patrick Mollat; Ramachandran Murali; Keiichi Ohya; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2006-05-04       Impact factor: 14.808

2.  Mapping protein-protein contact sites using cellulose-bound peptide scans.

Authors:  U Reineke; R Sabat; A Kramer; R D Stigler; M Seifert; T Michel; H D Volk; J Schneider-Mergener
Journal:  Mol Divers       Date:  1996-05       Impact factor: 2.943

3.  Decoy strategies: the structure of TL1A:DcR3 complex.

Authors:  Chenyang Zhan; Yury Patskovsky; Qingrong Yan; Zhenhong Li; Udupi Ramagopal; Huiyong Cheng; Michael Brenowitz; Xiao Hui; Stanley G Nathenson; Steven C Almo
Journal:  Structure       Date:  2011-02-09       Impact factor: 5.006

4.  Molecular cloning and characterization of beluga whale (Delphinapterus leucas) interleukin-1beta and tumor necrosis factor-alpha.

Authors:  F Denis; D Archambault
Journal:  Can J Vet Res       Date:  2001-10       Impact factor: 1.310

5.  Insights into ligand binding by a viral tumor necrosis factor (TNF) decoy receptor yield a selective soluble human type 2 TNF receptor.

Authors:  Sergio M Pontejo; Carolina Sanchez; Begoña Ruiz-Argüello; Antonio Alcami
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

6.  DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.

Authors:  Amanda L Gavin; Djemel Aït-Azzouzene; Carl F Ware; David Nemazee
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

7.  Biological activity of mutants of human tumour necrosis factor-alpha.

Authors:  R Kircheis; J Milleck; V G Korobko; L N Shingarova; D Behnke; H E Schmidt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

8.  Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity.

Authors:  D A Rathjen; A Ferrante; R Aston
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

9.  Biochemical and structural characterization of the human TL1A ectodomain.

Authors:  Chenyang Zhan; Qingrong Yan; Yury Patskovsky; Zhenhong Li; Rafael Toro; Amanda Meyer; Huiyong Cheng; Michael Brenowitz; Stanley G Nathenson; Steven C Almo
Journal:  Biochemistry       Date:  2009-08-18       Impact factor: 3.162

10.  The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosis factor superfamily.

Authors:  Eun-Young Won; Kiweon Cha; Jung-Sue Byun; Dong-Uk Kim; Sumi Shin; Byungchan Ahn; Young Ho Kim; Amanda J Rice; Thomas Walz; Byoung S Kwon; Hyun-Soo Cho
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.